Medication

1. Except as otherwise specifically provided by law, the commission adopts by reference: a. The association of racing commissioners international controlled therapeutic medication schedule version 14.4. b. The association of racing commissioner's international uniform classification guidelines for foreign substances and recommended penalties version 14.4. c. The model rules ARCI-011-020 section B(13)(a) through (j) of the association of racing commissioners international model rules of racing version 11.0. 2. Furosemide. a. Furosemide may be administered intravenously to a horse, which is entered to compete in a race. Except under the instructions of the official veterinarian or the racing veterinarian for the purpose of removing a horse from the veterinarian's list or to facilitate the collection of a post-race urine sample, furosemide shall be permitted only after the official veterinarian has placed the horse on the furosemide list. In order for a horse to be placed on the furosemide list the following process must be followed. (1) After the horse's licensed trainer and licensed veterinarian determine that it would be in the horse's best interests to race with furosemide the official veterinarian or the veterinarian's designee shall be notified using the prescribed form, that the horse is to be put on the furosemide list. (2) The form must be received by the official veterinarian or the veterinarian's designee by the proper time deadlines so as to ensure public notification. (3) A horse placed on the official furosemide list must remain on that list unless the licensed trainer and licensed veterinarian submit a written request to remove the horse from the list. The request must be made to the official veterinarian or the veterinarian's designee, on the proper form, no later than the time of entry. (4) After a horse has been removed from the furosemide list, the horse may not be placed back on the list for a period of sixty calendar days unless it is determined to be detrimental to the welfare of the horse, in consultation with the official veterinarian. If a horse is removed from the official furosemide list a second time in a three hundred sixty-five-day period, the horse may not be placed on the list for a period of ninety calendar days. (5) Furosemide shall only be administered on association grounds. (6) Furosemide shall be the only authorized bleeder medication. b. The use of furosemide shall be permitted under the following circumstances on association grounds where a detention barn is utilized: (1) Furosemide shall be administered by the official veterinarian or the veterinarian's designee no less than four hours prior to post time for the race for which the horse is entered. (2) A horse qualified for furosemide administration must be brought to the detention barn within time to comply with the four-hour administration requirement specified above. (3) The dose administered shall not exceed five hundred milligrams nor be less than one hundred fifty milligrams. (4) Furosemide shall be administered by a single, intravenous injection. (5) After treatment, the horse shall be required by the commission to remain in the detention barn in the care, custody, and control of its trainer or the trainer's designated representative under the association or commission security supervision, or both, until called to the saddling paddock. c. The use of furosemide shall be permitted under the following circumstances on association grounds where a detention barn is not utilized: (1) Furosemide shall be administered by the official veterinarian or the veterinarian's designee no less than four hours prior to post time for the race for which the horse is entered. (2) The furosemide dosage administered shall not exceed five hundred milligrams nor be less than one hundred fifty milligrams. (3) Furosemide shall be administered by a single, intravenous injection. (4) After treatment, the horse shall be required by the commission to remain in the proximity of its stall in the care, custody, and control of its trainer or the trainer's designated representative under general association or commission security surveillance, or both, until called to the saddling paddock. d. Test result must show a detectable concentration of the drug in the post-race serum, plasma, or urine sample. (1) The specific gravity of post-race urine samples may be measured to ensure the samples are sufficiently concentrated for proper chemical analysis. The specific gravity shall not be below 1.010. If the specific gravity of the urine is found to be below 1.010 or if a urine sample is unavailable for testing, quantitation of furosemide in serum or plasma shall be performed; (2) Quantitation of furosemide in serum or plasma shall be performed when the specific gravity of the corresponding urine sample is not measured or if measured below 1.010. Concentrations may not exceed 100 nanograms of furosemide per milliliter of serum or plasma. e. The administering authority or association may assess a fee approved by the commission on licensed owners of treated horses to recoup the reasonable costs associated with the administration of furosemide in the manner prescribed in these rules. 3. Bleeder list. a. The official veterinarian shall maintain a bleeder list of all horses, which have demonstrated external evidence of exercise induced pulmonary hemorrhage from one or both nostrils during or after a race or workout as observed by the official veterinarian. b. Every confirmed bleeder, regardless of age, shall be placed on the bleeder list and be ineligible to race for the following time periods: (1) First incident - Fourteen days; (2) Second incident within a three hundred sixty-five-day period - Thirty days; (3) Third incident within a three hundred sixty-five-day period - One hundred eighty days; (4) Fourth incident within a three hundred sixty-five-day period - Barred for racing lifetime. c. For the purposes of counting the number of days a horse is ineligible to run, the day the horse bled externally is the first day of the recovery period. d. The voluntary administration of furosemide without an external bleeding incident shall not subject the horse to the initial period of ineligibility as defined by this policy. e. A horse may be removed from the bleeder list only upon the direction of the official veterinarian, who shall certify in writing to the stewards the recommendation for removal. f. A horse which has been placed on a bleeder list in another jurisdiction pursuant to these rules shall be placed on a bleeder list in this jurisdiction. 4. Antiulcer medications. The following antiulcer medications are permitted to be administered, at the stated dosage, up to 24 hours prior to the race in which the horse is entered: a. Cimetidine (Tagamet®) - 8-20 mg/kg PO BID-TID. b. Opeprazole (Gastrogard®) - 2.2 grams PO SID. c. Rantidine (Zantac®) - 8 mg/kg PO BID.